Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Catalyst Pharmaceutical Partners Inc buy Oppenheimer Holdings Inc.

Start price
€15.07
27.03.24 / 50%
Target price
€26.80
27.03.25
Performance (%)
-8.60%
Price
€13.77
23.04.24
Summary
This prediction is currently active. With a performance of -8.60%, the BUY prediction by Oppenheimer_Holdings is trending in the wrong direction. This prediction currently runs until 27.03.25. The prediction end date can be changed by Oppenheimer_Holdings at any time. Oppenheimer_Holdings has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Catalyst Pharmaceutical Partners Inc -5.782% -5.782%
iShares Core DAX® 2.594% -1.158%
iShares Nasdaq 100 3.553% -1.727%
iShares Nikkei 225® 0.687% -8.354%
iShares S&P 500 2.209% -0.942%

Comments by Oppenheimer_Holdings for this prediction

In the thread Catalyst Pharmaceutical Partners Inc diskutieren
Prediction Buy
Perf. (%) -8.60%
Target price 26.802
Change
Ends at 27.03.25

Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $29.00 price target on the stock.
Ratings data for CPRX provided by MarketBeat

Stopped prediction by Oppenheimer_Holdings for Catalyst Pharmaceutical Partners Inc

buy
Catalyst Pharmaceutical Partners Inc

Start price
Target price
Perf. (%)
€14.09
21.12.23
€27.29
21.12.24
-2.27%
23.04.24